Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-118546·Boundless Bio, Inc.
Schedule 13G ownership disclosure
BOUNDLESS BIO INC
Common stock, par value $0.0001 per share (the "Shares") · CUSIP: 10170A100
Event date: 2025-11-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Citadel Advisors LLC
Shares: 830,936.00 · Class: 3.7%
- Citadel Advisors Holdings LP
Shares: 830,936.00 · Class: 3.7%
- Citadel GP LLC
Shares: 830,936.00 · Class: 3.7%
- Citadel Securities LLC
Shares: 602,452.00 · Class: 2.7%
- Citadel Securities Group LP
Shares: 602,452.00 · Class: 2.7%
- Citadel Securities GP LLC
Shares: 602,452.00 · Class: 2.7%
- Kenneth Griffin
Shares: 1,433,388.00 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-118546
- Form type
- SCHEDULE 13G
- Filer
- Boundless Bio, Inc.
- CIK
- CIK 1782303
- Filed
- Dec 04, 2025
- Reporting period
- Nov 26, 2025
- Description
- Schedule 13G beneficial ownership